Concepedia
Statistics
Publications
8
Citations
321
H-Index
Active since
2017
Affiliations
Nanjing Medical University(Current)
Jiangsu Cancer Hospital
Wannan Medical College
First Affiliated Hospital of Wannan Medical College
First Affiliated Hospital of Wenzhou Medical University
Mo Xiao is an author at Nanjing Medical University specializing in oncology, cancer cell signaling, and life sciences.
Publications per year
2017–2022
Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver
Tao Zeng, Cuili Zhang, Ning Zhao et al. · Redox Biology · 2017 · 113 citations · Full text
Life Sciences, Biochemistry, Toxicology +17
S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways
Dan Fang, Chengfei Zhang, Ping Xu et al. · Cell Biology and Toxicology · 2021 · 53 citations
Medicine, Cancer Biology, Oncology +14
STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway
Chengfei Zhang, Xiaoming Wang, Dan Fang et al. · Theranostics · 2020 · 44 citations · Full text
Medicine, Cell Biology, Oncology +17
KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma
Mo Xiao, Ping Xu, Min Ding et al. · Acta Pharmacologica Sinica · 2021 · 40 citations · Full text
Life Sciences, Cell Biology, Oncology +8
Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer
Hongjin Chen, Xiaoming Wang, Fubing Wu et al. · Genomics · 2020 · 24 citations
Life Sciences, Genetics, Oncology +15
1–5 of 8